FDA clearance for TearScience thermal pulsation system

FDA clearance for TearScience thermal pulsation system

TearScience has announced that it has received US Food and Drug Administration (FDA) clearance for its LipiFlowThermal Pulsation System for the treatment of meibomian gland dysfunction (MGD). The clearance enables TearScience to market and sell LipiFlow to eye care physicians in the US. LipiFlow will be available immediately, but on a limited basis in the US through the end of 2011.

Latest Articles
Organising for Success

Professional and personal goals drive practice ownership and operational choices.

Read more...

Update on Astigmatism Analysis

Read more...

Is Frugal Innovation Possible in Ophthalmology?

Improving access through financially and environmentally sustainable innovation.

Read more...

From Concept to Clinic

Partnerships with academia and industry promote innovation.

Read more...

Making IOLs a More Personal Choice

Surgeons may prefer some IOLs for their patients, but what about for themselves?

Read more...

Need to Know: Higher-Order Aberrations and Polynomials

This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.

Read more...

Never Go In Blind

Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.

Read more...

Simulators Benefit Surgeons and Patients

Helping young surgeons build confidence and expertise.

Read more...

How Many Surgeries Equal Surgical Proficiency?

Internet, labs, simulators, and assisting surgery all contribute.

Read more...

Improving Clinical Management for nAMD and DME

Global survey data identify barriers and opportunities.

Read more...